Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy

Enrica Tamburrini, Carmela Pinnetti, M Floridia, M Ravizza, C Tibaldi, A Bucceri, G Anzidei, M Fiscon, Alessandra Molinari, P Martinelli, S Dalzero

Risultato della ricerca: Contributo in rivistaArticolo in rivista

18 Citazioni (Scopus)

Abstract

To investigate the risk factors for an HIV-1 RNA plasma viral load above 400 copies/mL in the third trimester of pregnancy.
Lingua originaleEnglish
pagine (da-a)303-311
Numero di pagine9
RivistaHIV CLINICAL TRIALS
Volume11
DOI
Stato di pubblicazionePubblicato - 2010

Keywords

  • Adult
  • Anti-Retroviral Agents
  • CD4 Lymphocyte Count
  • Cohort Studies
  • Drug Administration Schedule
  • Female
  • HIV Infections
  • HIV-1
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical
  • Logistic Models
  • Pregnancy
  • Pregnancy Complications, Infectious
  • Pregnancy Trimester, Third
  • RNA, Viral
  • Risk Factors
  • Time Factors
  • Viral Load
  • Withholding Treatment
  • Young Adult

Fingerprint Entra nei temi di ricerca di 'Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy'. Insieme formano una fingerprint unica.

Cita questo